H
Hongliang Li
Researcher at Wuhan University
Publications - 438
Citations - 22248
Hongliang Li is an academic researcher from Wuhan University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 64, co-authored 378 publications receiving 16094 citations. Previous affiliations of Hongliang Li include Peking Union Medical College & Central South University.
Papers
More filters
Journal ArticleDOI
The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study
Guangwei Li,Ping Zhang,Jinping Wang,Edward W. Gregg,Wenying Yang,Qiuhong Gong,Hui Li,Hongliang Li,Yayun Jiang,Yali An,Ying Shuai,Bo Zhang,Jing-ling Zhang,Theodore J. Thompson,Robert B. Gerzoff,Gojka Roglic,Yinghua Hu,Peter H. Bennett +17 more
TL;DR: Group-based lifestyle interventions over 6 years can prevent or delay diabetes for up to 14 years after the active intervention, however, whether lifestyle intervention also leads to reduced CVD and mortality remains unclear.
Journal ArticleDOI
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes.
Lihua Zhu,Zhi-Gang She,Xu Cheng,Juan Juan Qin,Xiao Jing Zhang,Jingjing Cai,Fang Lei,Haitao Wang,Jing Xie,Wenxin Wang,Haomiao Li,Peng Zhang,Xiaohui Song,Xi Chen,Xiang Mei,Chaozheng Zhang,Liangjie Bai,Da Xiang,Ming Ming Chen,Yanqiong Liu,Youqin Yan,Mingyu Liu,Weiming Mao,Jinjing Zou,Liming Liu,Guohua Chen,Pengcheng Luo,Bing Xiao,Changjiang Zhang,Zixiong Zhang,Zhigang Lu,Junhai Wang,Haofeng Lu,Xigang Xia,Daihong Wang,Xiaofeng Liao,Gang Peng,Ping Ye,Jun Yang,Yufeng Yuan,Xiaodong Huang,Jiao Guo,Bing Hong Zhang,Hongliang Li +43 more
TL;DR: Clinical evidence correlating improved glycemic control with better outcomes in patients with COVID-19 and pre-existing T2D is provided, associated with markedly lower mortality compared to individuals with poorly controlled BG during hospitalization.
Journal ArticleDOI
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19.
Peng Zhang,Lihua Zhu,Jingjing Cai,Fang Lei,Juan-Juan Qin,Jing Xie,Ye-Mao Liu,Yan-Ci Zhao,Xuewei Huang,Lijin Lin,Meng Xia,Ming-Ming Chen,Xu Cheng,Xiao Zhang,Deliang Guo,Yuanyuan Peng,Yan-Xiao Ji,Jing Chen,Zhi-Gang She,Yibin Wang,Qingbo Xu,Renfu Tan,Haitao Wang,Jun Lin,Pengcheng Luo,Shouzhi Fu,Hongbin Cai,Ping Ye,Bing Xiao,Weiming Mao,Liming Liu,Youqin Yan,Mingyu Liu,Manhua Chen,Xiao-Jing Zhang,Xinghuan Wang,Rhian M. Touyz,Jiahong Xia,Bing-Hong Zhang,Xiaodong Huang,Yufeng Yuan,Rohit Loomba,Peter P. Liu,Hongliang Li +43 more
TL;DR: Among hospitalized patients with COVID-19 and coexisting hypertension, inpatient use of ACEI/ARB was associated with lower risk of all-cause mortality compared with ACEi/ARB nonusers, and it is unlikely that in-hospital use ofACEI/ARB wasassociated with an increased mortality risk.
Journal ArticleDOI
The Science Underlying COVID-19: Implications for the Cardiovascular System.
TL;DR: Persistent immune activation in predisposed patients, such as the elderly and those with CV risk, can lead to hemophagocytosis like syndrome, with uncontrolled amplification of cytokine production, leading to multi-organ failure and death.
Journal ArticleDOI
Synergetic interaction between neighbouring platinum monomers in CO 2 hydrogenation.
Hongliang Li,Liangbing Wang,Yizhou Dai,Pu Zhengtian,Zhuohan Lao,Yawei Chen,Menglin Wang,Xusheng Zheng,Junfa Zhu,Wenhua Zhang,Rui Si,Chao Ma,Jie Zeng +12 more
TL;DR: It is demonstrated that the synergetic interaction between neighbouring Pt monomers on MoS2 greatly enhanced the CO2 hydrogenation catalytic activity and reduced the activation energy relative to isolated monomers.